Literature DB >> 15820279

Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern.

Tushar V Salukhe1, Darrel P Francis, Jonathan R Clague, Richard Sutton, Philip Poole-Wilson, Michael Y Henein.   

Abstract

BACKGROUND: Cardiac resynchronization fails to improve symptoms in up to one third of patients meeting criteria for this treatment, for reasons which are unclear. Indeed, the very mechanism of benefit from resynchronization is controversial. Resynchronization may work by improving ventricular filling: we tested the hypothesis that benefit from resynchronization depends on filling pattern. METHODS AND
RESULTS: We assessed symptoms (NYHA class) and LV filling of 40 patients with chronic heart failure and prolonged QRS who underwent resynchronization. Fifteen had restrictive filling pattern (E velocity>or=1.0 m/s, E/A ratio>1 and E wave deceleration time<or=140 ms) and 25 had late filling pattern (single isolated A wave or summation wave filling in late diastole). At 6 months, the patients with restrictive filling failed to show the improvements observed in those with late filling. They failed to reduce NYHA class (DeltaNYHA: 27% improved one class, 66% unchanged, 7% worsened one class, P=NS; vs. 8% improved two classes, 72% improved one class and 20% unchanged, P<0.001; difference between groups, P<0.001). They failed to reduce LV end-diastolic dimension (DeltaLVEDD -0.04 cm, P=NS; vs. -0.6, P<0.001; difference between groups, P<0.05) or end-systolic dimension (DeltaLVESD -0.01 cm, P=NS; vs. -0.6, P<0.001; difference between groups, P<0.05). They failed to improve cardiac cycle efficiency (Deltatotal isovolumic [wasted] time 2.1 s/min, P=NS; vs. -5.4 s/min; difference between groups, P<0.001).
CONCLUSION: Among patients routinely eligible for resynchronization, those with restrictive filling may show significantly less (and possibly no) improvement in symptom class and ventricular dimensions after resynchronization. Their failure to improve cardiac cycle efficiency may account for their attenuated clinical benefit.

Entities:  

Mesh:

Year:  2005        PMID: 15820279     DOI: 10.1016/j.ijcard.2005.01.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Apex techniques, old and new, hold the key to estimated left ventricular end-diastolic and right ventricular systolic pressure.

Authors:  Robin Chung; Michael Y Henein
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-28       Impact factor: 2.357

2.  Optimized multisite ventricular pacing in postoperative single-ventricle patients.

Authors:  Vinod Havalad; Santos E Cabreriza; Eva W Cheung; Linda Aponte-Patel; Alice Wang; Bin Cheng; Daniel Y Wang; Eric Silver; Emile A Bacha; Henry M Spotnitz
Journal:  Pediatr Cardiol       Date:  2014-05-15       Impact factor: 1.655

3.  Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy.

Authors:  Eduardo Arrais Rocha; Francisca Tatiana Moreira Pereira; José Sebastião Abreu; José Wellington O Lima; Marcelo de Paula M Monteiro; Almino Cavalcante Rocha Neto; Ana Rosa Pinto Quidute; Camilla Viana A Goés; Carlos Roberto Martins Rodrigues Sobrinho; Maurício Ibrahim Scanavacca
Journal:  Arq Bras Cardiol       Date:  2015-09-04       Impact factor: 2.000

4.  Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy.

Authors:  Qi Wang; Kang-Yu Chen; Fei Yu; Hao Su; Chun-Sheng An; Yang Hu; Dong-Mei Yang; Jian Xu; Ji Yan
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.